- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02053428
Comparison of Percutaneous Image-guided Gastrostomies
November 14, 2014 updated by: University Health Network, Toronto
Comparison of Percutaneous Image-guided Gastrostomies: A Single Centre Pilot Study
Percutaneous image-guided gastrostomy (PIG) is an increasingly popular technique of creating gastroenteric access through the anterior abdominal wall for nutrition and/ or compression.
Large-bore mushroom-retained catheters via the pull technique and small-bore cope loop catheters via the push technique are both used at Interventional Radiology for PIG at our institution.
To date, there is no guideline for PIG and no direct comparison of two PIG techniques.
The proposed pilot study is to compare the two different types of PIG techniques in head and neck cancer patients who require prophylactic enteral feeding by PIG.
The purpose of the study is to assess the feasibility of a large randomized clinical trial to compare these two PIG techniques.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 2N2
- University Health Network
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female ≥18 years;
- Life expectancy > 6 months;
- Diagnosed with head and neck cancer; and
- Scheduled to have prophylactic enteral feeding by percutaneous image-guided gastrostomy performed in the interventional radiology suite.
Exclusion Criteria:
- Pregnancy; or
- Established pharyngeal obstruction and/or presence of an enteral feeding device.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Gastrostomy - pull technique
Percutaneous image-guided gastrostomy using large-bore mushroom-retained catheters via the pull technique
|
|
|
Active Comparator: Gastrostomy - push technique
Percutaneous image-guided gastrostomy using small-bore cope loop catheters via the push technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain experience
Time Frame: pre, 1-hour, 2-hour, 3-hour, 1-day, 2-day, 3-day and weekly for up to six weeks post procedure
|
The primary objective of this study is to compare the level of pain experienced, measured by the dose of sedation used during the procedure, and numerical rating scale (NRS)
|
pre, 1-hour, 2-hour, 3-hour, 1-day, 2-day, 3-day and weekly for up to six weeks post procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Technical success
Time Frame: Day 0 post procedure
|
successful placement of percutaneous image-guided gastrostomy
|
Day 0 post procedure
|
|
Catheter malfunction rate
Time Frame: Up to six months post procedure
|
tube clogging, dislodgement and/or leakage
|
Up to six months post procedure
|
|
Tube site complications
Time Frame: Up to six months post procedure
|
Skin infection on tube exit
|
Up to six months post procedure
|
|
Quality of life
Time Frame: Up to six weeks post procedure
|
Quality of life for patients undergoing different types of PIG procedures.
|
Up to six weeks post procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Kong Teng Tan, MB BCH BAO, University Health Network, Toronto
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
October 1, 2014
Study Registration Dates
First Submitted
January 21, 2014
First Submitted That Met QC Criteria
January 31, 2014
First Posted (Estimate)
February 3, 2014
Study Record Updates
Last Update Posted (Estimate)
November 17, 2014
Last Update Submitted That Met QC Criteria
November 14, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-0298B
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer of Head and Neck
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Bristol-Myers SquibbOno Pharma USA IncCompletedCancer of Head and Neck | Cancer of the Head | Cancer of the NeckJapan
-
AstraZenecaCompletedCancer of Head and NeckSpain
-
Washington University School of MedicineCelgene CorporationCompletedHead and Neck Cancer | Squamous Cell Carcinoma of the Head and Neck | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and Neck | Carcinoma, Squamous Cell of the Head and NeckUnited States
-
University of Alabama at BirminghamAventis PharmaceuticalsCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neck NeoplasmsUnited States
-
Bristol-Myers SquibbCompletedSquamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and NeckFrance
-
Royal Marsden NHS Foundation TrustRecruitingHead and Neck CancerUnited Kingdom
-
University of ChicagoCompletedHead and Neck CancerUnited States
-
Washington University School of MedicineTerminatedHead and Neck Cancer | Cancer of the Head and NeckUnited States
Clinical Trials on percutaneous image-guided gastrostomy
-
Great Ormond Street Hospital for Children NHS Foundation...UnknownTwo Interventions (PEG and RIG) Compared Against Each OtherUnited Kingdom
-
Instituto do Cancer do Estado de São PauloAngiodynamics, Inc.Recruiting
-
University of Maryland, BaltimoreWithdrawnRespiratory Failure | Gastrostomy | Ventilatory FailureUnited States
-
CoapTechLondon Health Sciences CentreCompleted
-
Mayo ClinicCompletedGastrostomy TubeUnited States
-
University of ArizonaNot yet recruitingMalignancy-induced Pelvic PainUnited States
-
Okan UniversityCompletedNutrition Disorders | GastrostomyTurkey
-
Mahidol UniversityTerminatedCarcinoma, Squamous Cell of Head and NeckThailand
-
The Catholic University of KoreaIntroMedic Co., Ltd.UnknownDysphagia | Aspiration | Esophageal StenosisKorea, Republic of
-
Vanderbilt UniversityTerminated